Johnson & Johnson JNJ:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 6:54 AM EDT

151.31

+0.13 (+0.09%)

Volume

2,175

151.18

+6.59 (+4.56%)

Volume

13,363,944

52 week range

143.13 - 175.97

Open0.00
Day High0.00
Day Low0.00
Prev Close151.18
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24

Key Stats

Market Cap364.311B
Shares Out2.41B
10 Day Average Volume8.81M
Dividend4.96
Dividend Yield3.28%
Beta0.55
YTD % Change-3.55

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close151.18
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24
Market Cap364.311B
Shares Out2.41B
10 Day Average Volume8.81M
Dividend4.96
Dividend Yield3.28%
Beta0.55
YTD % Change-3.55

RATIOS/PROFITABILITY

EPS (TTM)6.69
P/E (TTM)22.60
Fwd P/E (NTM)14.31
EBITDA (TTM)29.873B
ROE (TTM)18.31%
Revenue (TTM)81.796B
Gross Margin (TTM)70.22%
Net Margin (TTM)22.92%
Debt To Equity (MRQ)42.65%

EVENTS

Earnings Date07/17/2024(est)
Ex Div Date05/20/2024
Div Amount1.24
Split Date-
Split Factor-

Latest On Johnson & Johnson

Cramer's thoughts on AMD, Johnson & Johnson, CVS Health, Super Micro and Pinterest20 Hours AgoCNBC.com
Wednesday’s rapid fire: AMD, Johnson & Johnson, CVS Health, Super Micro and Pinterest20 Hours AgoCNBC.com
Jim Cramer's top 10 things to watch in the stock market Wednesday22 Hours AgoCNBC.com
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.23 Hours AgoCNBC.com
5 things to know before the stock market opens Wednesday24 Hours AgoCNBC.com

Content From Our Affiliates

Johnson & Johnson’s Strategic Settlement Plan for Ovarian Cancer Talc Claims: Financial Implications and Outlook2 Hours AgoTipRanks
Johnson & Johnson (NYSE:JNJ) Is Paying $6.5B to Settle Lawsuit19 Hours AgoTipRanks
Johnson & Johnson Announces Major Talc Litigation Settlement Plan24 Hours AgoTipRanks
J&J says talc plan commits company to pay claimants $6.475BMay 1, 2024TipRanks
Johnson & Johnson management to meet with OppenheimerMay 1, 2024TipRanks

Profile

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...

Joaquin Duato

Chairman of the Board, Chief Executive Officer

Joseph Wolk

Chief Financial Officer, Executive Vice President

Tim Schmid

Executive Vice President, Worldwide Chairman of MedTech

Elizabeth Forminard

Executive Vice President, General Counsel

John Reed M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

Address

One Johnson & Johnson Plaza

New Brunswick, NJ

08933

United States

https://www.jnj.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	128.80	-0.42	-0.33%
ABBV AbbVie Inc	161.72	-0.92	-0.57%
AZN AstraZeneca PLC	76.41	+0.53	+0.70%
RHHBY Roche Holding AG	29.75	UNCH	UNCH
NVS Novartis AG	97.50	+0.37	+0.38%